Encube is an integrated pharmaceutical company dedicated to topical formulations with 23+ years of experience in contract development and manufacturing. Our manufacturing facility in Madkaim - Goa, India is the largest single-site topical manufacturing facility in the world, dedicated to prescription and OTC pharmaceuticals, and cosmetic semisolid dosage forms. Encube’s R&D Centre in Mumbai, India houses a team of 150+ scientists working for the formulation development of topical products.
Location: India, Maharashtra, Mumbai
Employees: 501-1000
Phone: +91 22 6228 8000
Founded date: 1998
Investors 2
| Date | Name | Website |
| - | Multiples ... | multiplese... |
| - | Quadria Ca... | quadriacap... |
Mentions in press and media 4
| Date | Title | Description |
| 14.11.2025 | PE-backed Encube Ethicals eyes fresh cheque from buyout funds | Pro Credit: Pexels Encube Ethicals Pvt Ltd, a contract development and manufacturing firm focused on topical drugs, is gearing up for a fresh private funding round that will enable an exit for some of its early backers, multiple people fami... |
| 14.01.2025 | Quadria Capital's $100 Million Bet on Aragen: A Strategic Move in Pharma Outsourcing | In the ever-evolving landscape of pharmaceuticals, the recent $100 million investment by Quadria Capital in Aragen Life Sciences marks a significant milestone. This deal, announced on January 13, 2025, positions Aragen as a key player in th... |
| 13.01.2025 | Quadria bets $100 mn on IPO-bound contract drugs manufacturer Aragen | Manni Kantipudi, CEO, Aragen Life Sciences Healthcare-focused private equity firm Quadria Capital is investing $100 million (about Rs 860 crore) in Hyderabad-based contract drug development and manufacturing company Aragen Life Sciences Ltd... |
| 13.01.2025 | Quadria Capital invests $100 million in Aragen to boost pharma outsourcing services | Contract research, development and manufacturing organisation Aragen has secured a $100 million investment from Quadria Capital, an Asia healthcare-focused private equity fund. This gives Quadria a minority stake in Aragen, at a valuation o... |